Attainment of lipid goals and long-term mortality after coronary-artery bypass surgery

Barak Zafrir1,2, Walid Saliba2,3, Ronen Jaffe1,2

  • 11 Department of Cardiology, Lady Davis Carmel Medical Center and Clalit Health Services, Haifa, Israel.

Insights

Attaining optimal lipid levels after coronary-artery bypass graft surgery (CABG) is crucial. Poor lipid control, including high low-density lipoprotein cholesterol (LDL-C), is linked to increased long-term mortality risk post-CABG.

Area of Science:

  • Cardiovascular Surgery
  • Lipid Metabolism
  • Clinical Outcomes Research

Background:

  • Limited data exists on lipid goal attainment post-coronary-artery bypass graft surgery (CABG).
  • The impact of post-CABG lipid levels on adverse outcomes requires further investigation.

Purpose of the Study:

  • To assess lipid goal attainment in patients after CABG.
  • To determine the association between achieved plasma lipid levels and long-term mortality.

Main Methods:

  • Retrospective analysis of 1230 patients who underwent CABG.
  • Mortality was analyzed concerning post-operative lipid levels (LDL-C, HDL-C, triglycerides) and pre-operative improvements.

Main Results:

  • Only 44% of patients achieved target LDL-C (<70 mg/dL).
  • Higher LDL-C, lower HDL-C, and elevated triglycerides were independently associated with increased long-term mortality.
  • Optimal levels of all lipid measures significantly reduced mortality risk (P < 0.0001).

Conclusions:

  • Suboptimal lipid levels are common after CABG and significantly increase long-term mortality risk.
  • Addressing plasma lipid profiles is vital as both a risk marker and a treatment target post-CABG.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
451
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
269
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
536
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
373
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
693